Bosentan: a dual endothelin receptor antagonist

Expert Opinion on Investigational Drugs - Tập 11 Số 7 - Trang 991-1002 - 2002
Sébastien Roux1, Lewis J. Rubin2
1University of California, San Diego, San Diego, United States
2Division of Pulmonary & Critical Care Medicine, Department of Medicine, University of California at San Diego, School of Medicine, 9300 Campus Point Drive, 7372, La Jolla, CA 92037, USA.

Tóm tắt

Từ khóa


Tài liệu tham khảo

HAYNES WG, 1993, Sci., 84, 485

LEVIN ER, 1995, N Engl. I Med, 356, 10.1056/NEJM199508103330607

10.1172/JCI116338

10.1161/01.CIR.93.4.646

10.1161/01.HYP.33.2.753

ABRAHAM DJ, 1997, Am. J. Pathol., 151, 831

10.1161/hc0902.105719

10.1161/01.HYP.35.2.648

10.1097/00024382-200013010-00013

10.1006/bbrc.1994.1395

10.1161/01.RES.69.1.209

10.1165/ajrcmb/7.5.492

10.1164/ajrccm.165.3.2104059

10.1165/ajrcmb.23.1.f192

10.1210/jcem.82.10.4279

10.1056/NEJM199306173282402

10.1016/S0008-6363(99)00230-8

10.1161/01.RES.73.5.887

10.1016/S0008-6363(96)00189-7

10.1161/01.CIR.84.6.2280

10.1378/chest.104.1.236

10.1056/NEJM199608293350901

10.1016/S0140-6736(98)02111-4

10.1056/NEJM199701093360207

10.7326/0003-4819-107-2-216

D'ALONZO GE, 1991, Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann. Intern. Med., 115, 343

10.1002/art.1780290409

10.1016/S0735-1097(97)00187-3

10.1038/79226

10.1136/jmg.37.10.741

10.1056/NEJM199207093270203

10.1161/01.CIR.76.1.135

10.7326/0003-4819-132-6-200003210-00002

10.1056/NEJM199602013340504

10.7326/0003-4819-121-6-199409150-00003

10.2165/00003495-199856060-00004

10.1111/j.1476-5381.1994.tb13153.x

CARRATU P, 1997, Am. Physiol., 272, L1021–L1024

10.1093/cvr/27.12.2125

10.1111/j.1476-5381.1996.tb16013.x

CLOZEL M, 1994, Pharmacol Exp. The], 270, 228

10.1007/s001090050363

10.1139/y98-001

10.1016/S0003-4975(00)01820-8

10.1007/s002100000264

HESS P, 1996, ' Appl. Physiol, 81, 1027, 10.1152/jappl.1996.81.2.1027

CHEN S-J, CHEN Y-F, MENG QC, DURAND J, DICARLO VS, OPARIL, 1995, Appl Physiol, 79, 2122, 10.1152/jappl.1995.79.6.2122

EDDAHIBI S, 1995, Am. Physiol, 268, H828–H835

10.1016/S0022-5223(96)70088-0

10.1097/00024382-199705000-00009

10.1034/j.1399-3003.2000.15d04.x

10.1164/ajrccm.156.2.9607123

10.1161/01.CIR.96.6.1976

10.1016/S0735-1097(99)00528-8

10.1016/S0014-2999(01)01133-5

10.1111/j.1476-5381.1995.tb15868.x

10.1016/0304-3959(95)00106-9

10.1016/S0140-6736(95)91504-4

10.1161/01.CIR.98.21.2262

WEBER C, 1999, Drug Metabol Dispos., 27, 810

10.1177/00912709922008344

10.1016/S0009-9236(96)90127-7

10.1177/00912709922008380

10.1046/j.1365-2125.1999.00946.x

VAN GIERSBERGEN PLM, CLOZEL M, BODIN F, 2001, [Abstract] Clin. Pharmacol Ther., 69, P67

10.1177/00912700222011300

10.1056/NEJMoa012212

BELCH JJF, 1989, CurcOpin. Rheumatol, 1, 490

TAMAKI T, 1991, Epidemiological study of patients with systemic sclerosis in Tokyo. Arch. Dermatol Res., 283, 366